Skip to main content
SpringerLink
Log in

Development of Vaccines Based on Formulations Containing Nonionic Block Copolymers

  • Chapter
Vaccine Design

Part of the book series: Pharmaceutical Biotechnology ((PBIO,volume 6))

Abstract

This chapter focuses on the capacity of vaccine formulations containing synthetic nonionic block polymers to modify or augment immune responses to current vaccines and some vaccines under development. These polymers are surface-active agents that can be formulated alone with antigens or as part of hydrophobic delivery vehicles. In current licensed human vaccines, improvements can be made to increase vaccine immunogenicity so that they can be administered in fewer injections, or so that seroconversion rates can be increased in target populations. Subunit antigen vaccines under development can lack potency, which can be significantly enhanced if formulated with an adjuvant or given in the appropriate delivery system. The capacity to induce a protective immune response can be induced by incorporating immunogens into delivery systems. These delivery systems include molecules and preparations classified as adjuvants, antigen encapsulation strategies, antigen targeting techniques, pulsatile release vehicles, live vectors, and other systems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Afonso, L. C. C., Scharton, T. M., Vieira, L. Q., Wysocka, M., Trinchieri, G., and Scott, P., 1994, The adjuvant effect of interleukin-12 in a vaccine against Leishmania major, Science 263:235–237.

    Article  PubMed  CAS  Google Scholar 

  • Allison, A. C., and Byars, N. E., 1990, Adjuvant formulations and their mode of action, Semin. Immunol. 2:369–374.

    PubMed  CAS  Google Scholar 

  • Alving, C. R., 1993, Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants, Immunobiology 187:430–446.

    Article  PubMed  CAS  Google Scholar 

  • Alving, C. R., Verma, J. N., Rao, M., Krzych, U., Amselem, S., Green, S. M., and Wassef, N. M., 1992, Liposomes containing lipid A as a potent non-toxic adjuvant, Res. Immunol. 143:197–198.

    Article  PubMed  CAS  Google Scholar 

  • Audibert, F. M., and Lise, L. D., 1993, Adjuvants: Current status, clinical perspectives and future prospects, Immunol. Today 14:281–284.

    Article  PubMed  CAS  Google Scholar 

  • Butterly, L., Watkins, E., and Dienstag, J. L., 1989, Recombinant-yeast derived hepatitis B vaccine in healthy adults: Safety and two-year immunogenicity of early investigative lots of vaccine, J. Med. Virol. 27:155–159.

    Article  PubMed  CAS  Google Scholar 

  • Byars, N. E., Allison, A. C., Harmon, M. W., and Kendal, A. P., 1990, Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation, Vaccine 8:49–56.

    Article  PubMed  CAS  Google Scholar 

  • Byars, N. E., Nakano, G., Welch, M., Lehman, D., and Allison, A. C., 1991, Improvement of hepatitis B vaccine by the use of a new adjuvant, Vaccine 9:309–318.

    Article  PubMed  CAS  Google Scholar 

  • Chu, C. T., and Pizzo, S. V., 1993, Receptor-mediated antigen delivery into macrophages, J. Immunol. 150:48–58.

    PubMed  CAS  Google Scholar 

  • Clerici, M., Lucey, D. R., Berzovsky, J.A., Pinto, L. A., Wynn, T. A., Blatt, S. A., Dolan, M. J., Hendrix, C. W., Wolf, S.W., and Shearer, G. M., 1993, Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro, Science 262:1721–1724.

    Article  PubMed  CAS  Google Scholar 

  • Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., and Gilley, R. M., 1991, Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin neutralizing antibodies, Infect. Immun. 59:2978–2986.

    PubMed  CAS  Google Scholar 

  • Germain, R. N., and Margulies, D. H., 1993, The biochemistry and cell biology of antigen processing and presentation, Annu. Rev. Immunol. 11:403–540.

    Article  PubMed  CAS  Google Scholar 

  • Ghalib, H. W., Piuvezam, M. R., Skeiky, Y. A., Siddig, M., Hashim, F. A., el Hassan, A., Russo, D. M., and Reed, S. G., 1993, Interleukin 10 production correlates with pathology in human Leishmania donovani infections, J. Clin. Invest. 92:324–329.

    Article  PubMed  CAS  Google Scholar 

  • Good, M. F., Pombo, D., Lunde, M. N., Maloy, W. L., Halenbeck, R., Koths, K., Miller, L. H., and Berzofsky, J. A., 1988a, Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2, J. Immunol. 141:972–977.

    PubMed  CAS  Google Scholar 

  • Good, M. F., Pombo, D., Quakyi, I. A., Riley, E. M., Houghten, R. A., Menon, A., Alling, D. W., Berzofsky, J. A., and Miller, L. H., 1988b, Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule, Proc. Natl. Acad. Sci. USA 85:1199–1203.

    Article  PubMed  CAS  Google Scholar 

  • Haigwood, N. L., Nara, P. L., Brooks, E., Van Nest, G., Ott, G., Higgins, K. W., Dunlop, N., Scandella, C. J., Eichberg, J. W., and Steimer, K. S., 1992, Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons, J. Virol. 66:172–182.

    PubMed  CAS  Google Scholar 

  • Hilleman, M. R., 1967, Considerations for safety and application of emulsified oil adjuvants to viral vaccines, in: International Symposium on Adjuvants of Immunity, Utrecht, 1966, Karger, Basel, pp. 13–26.

    Google Scholar 

  • Hilleman, M. R., Woodhur, A., and Friedman, A., 1972, The clinical application of adjuvant 65, Ann. Allergy 30:152–158.

    PubMed  CAS  Google Scholar 

  • Howerton, D. A., Hunter, R. L., Ziegler, H. K., and Check, I. J., 1990, Induction of macrophage Ia expression in vivo by a synthetic block polymer, L81, J. Immunol. 144:1578–1584.

    PubMed  CAS  Google Scholar 

  • Hunter, R. L., and Bennett, B., 1984, The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers, J. Immunol. 133:3167–3175.

    PubMed  CAS  Google Scholar 

  • Hunter, R. L., and Bennett, B., 1986, The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces, Scand. J. Immunol. 23:287–300.

    Article  PubMed  CAS  Google Scholar 

  • Hunter, R. L., Strickland, F., and Kezdy, F., 1981, The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance, J. Immunol. 127:1244–1250.

    PubMed  CAS  Google Scholar 

  • Hunter, R., Olsen, M., and Buynitzky, 1991, Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody, Vaccine 9:250–256.

    Article  PubMed  CAS  Google Scholar 

  • Hunter, R. L., Kidd, M. R., Olsen, M. R., Patterson, P. S., and Lal, A. A., 1994, Induction of long-lasting immunity to P. yoelii malaria using whole blood-stage antigen and copolymer adjuvants, (submitted).

    Google Scholar 

  • Inselburg, J., Bathurst, I. C., Kansopon, J., Barr, P. J., and Rossan, R., 1993, Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: Further studies using SERA1 and MF75.2 adjuvant, Infect. Immun. 61:2048–2052.

    PubMed  CAS  Google Scholar 

  • Institute of Medicine Committee on the Children’s Vaccine Initiative, 1993, The Children’s Vaccine Initiative (V. S. Mitchell, N. M. Philipose, and J. P. Sanford, eds.), National Academy Press, Washington, DC.

    Google Scholar 

  • Kalish, M. L., Check, I. J., and Hunter, R. L., 1991, Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5, J. Immunol. 146:3583–3590.

    PubMed  CAS  Google Scholar 

  • Keitel, W., Couch, R., Bond, N., Adair, S., Van Nest, G., and Dekker, C., 1993, Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant, Vaccine 11:909–913.

    Article  PubMed  CAS  Google Scholar 

  • Kensil, C. R., Patel, U., Lennick, M., and Marciani, D., 1991, Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex, J. Immunol. 146:431–437.

    PubMed  CAS  Google Scholar 

  • Lanzavecchia, A., 1993, Identifying strategies for immune intervention, Science 260:937–944.

    Article  PubMed  CAS  Google Scholar 

  • Livingston, P. O., Adluri, S., Raychaudhuri, S., Hughes, M. H., Calves, M. J., and Merritt, J. A., 1994, A phase I trial of the immunological adjuvant SAFm in melanoma patients vaccinated with the anti-idiotype antibody MELIMMUNEâ„¢, Vaccine Res. 3:71–81.

    Google Scholar 

  • Meuer, S. C., 1989, Low dose interleukin-2 induces systemic immune response against HBsAg in immunodeficient non-responders to hepatitis B vaccination in dialysis patients, Lancet 1:15–18.

    Article  PubMed  CAS  Google Scholar 

  • Millet, P., Kalish, M. L., Collins, W. E., and Hunter, R. L., 1992, Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine, Vaccine 10:547–550.

    Article  PubMed  CAS  Google Scholar 

  • Mosmann, T. R., and Coffman, R. L., 1989, TH1 and TH2 cells: Different pattern of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol. 7:145–173.

    Article  PubMed  CAS  Google Scholar 

  • Page, W. F., Norman, J. E., and Benenson, A. S., 1993, Long-term follow-up of army recruits immunized with Freund’s incomplete adjuvanted vaccine, Vaccine Res. 2:141–149.

    Google Scholar 

  • Potter, C. W., Jennings, R., Phair, J. P., Clarke, A., and Stuart-Harris, C. H., 1977, Dose-response relationship after immunization of volunteers with a new, surface antigen-adsorbed influenza virus vaccine, J. Infect. Dis. 135:423–431.

    Article  PubMed  CAS  Google Scholar 

  • Raychaudhuri, S., Tonks, M., Carbone, F., Ryskamp, T., and Morrow, J.W., 1992, Induction of antigen-specific class I-restricted cytotoxic T cells by soluble protein in vivo, Proc. Natl. Acad. Sci. USA 89:8308–8312.

    Article  PubMed  CAS  Google Scholar 

  • Rock, K. L., Fleischacker, G., and Gamble, S., 1993, Peptide-priming of cytolytic T cell immunity in vivo using β2-microglobulin as an adjuvant, J. Immunol. 150:1244–1252.

    PubMed  CAS  Google Scholar 

  • Sanchez-Pescador, L., Burke, R. L., Ott, G., and Van Nest, G., 1988, The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine, J. Immunol. 141:1720–1727.

    PubMed  CAS  Google Scholar 

  • Schirmbeck, R., Melber, K., Kuhrober, A., Janowicz, Z. A., and Reimann, J., 1994, Immunization with soluble hepatitis B virus specific surface protein elicits murine H-2 class-I restricted cytotoxic T lymphocyte responses in vivo, J. Immunol. 152:1110–1119.

    PubMed  CAS  Google Scholar 

  • Scott, P., 1991, IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis, J. Immunol. 147:3149–3155.

    PubMed  CAS  Google Scholar 

  • Scott, P., Pearce, E., Cheever, A. W., Coffman, R. L., and Sher, A., 1989, Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease, Immunol. Rev. 112:161–182.

    Article  PubMed  CAS  Google Scholar 

  • Sempertegui, F., Estrella, B., Moscoso, J., Piedrahita, L., Hernandez, D., Gaybor, J., Naranjo, P., Mancero, O., Arias, S., Bernai, R., Cordova, M. E., Suarez, J., and Zicker, F., 1994, Safety, immunogenicity and protective effect of SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador, Vaccine 12:337–342.

    Article  PubMed  CAS  Google Scholar 

  • Skea, D. L., and Barber, B. H., 1993, Adhesion-mediated enhancement of the adjuvant activity of alum, Vaccine 11:1018–1026.

    Article  PubMed  CAS  Google Scholar 

  • Takayama, K., Olsen, M., Datta, P., and Hunter, R. L., 1991, Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors, Vaccine 9:257–265.

    Article  PubMed  CAS  Google Scholar 

  • ten Hagen, T. L. M., Sulzer, A. J., Kidd, M. R., Lal, A. A., and Hunter, R. L., 1993, Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines, J. Immunol. 151:7077–7085.

    PubMed  Google Scholar 

  • Teusher, T., Armstrong-Schellenberg, J. R. M., Bastos de Azvedo, I., Hurt, N., Smith, T., Hayes, R., Masanja, H., Silva, Y., Lopez, M. C., Kitua, A., Kilama, W., Tanner, M., and Alonzo, P. L., 1994, SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission, Vaccine 12:328–336.

    Article  Google Scholar 

  • Townsend, A., and Bodmer, H., 1989, Antigen recognition by class I-restricted T lymphocytes, Annu. Rev. Immunol. 7:601–624.

    Article  PubMed  CAS  Google Scholar 

  • Van Dam, GJ., Verheul, A. F. M., Zigterman, G. J. W. J., De Reuver, M. J., and Snippe, H., 1989, Nonionic block polymer surfactants enhance the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 2 in normal and Xid mice, J. Immunol. 143:3049–3053.

    PubMed  Google Scholar 

  • Van de Wijgert, J. H. H. M., Verheul, A. F. M., Snippe, H., Check, I. J., and Hunter, R. L., 1991, Immunogenicity of Streptococcus pneumoniae type 14 capsular Polysaccharide: Influence of carriers and adjuvants on isotype distribution, Infect. Immun. 59:2750–2757.

    PubMed  Google Scholar 

  • Weissman, J. Y., Tsuchiyose, M. M., Tong, M. J., Co, R., Chin, K., and Ettenger, R. B., 1988, Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine, J. Am. Med. Assoc. 260:1734–1738.

    Article  CAS  Google Scholar 

  • Wintsch, J., Chaignat, C.-L., Braun, D.G., Jeannet, M., Stadler, H., and Abrignanai, S., 1991, Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccine, J. Infect. Dis. 163:219–225.

    Article  PubMed  CAS  Google Scholar 

  • Zigterman, G. J. W. J., Snippe, H., Jansze, M., and Willers, J. M. N., 1987, Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response, J. Immunol. 138:220–225.

    PubMed  CAS  Google Scholar 

  • Zigterman, G. J. W. J., Snippe, H., Jansze, M., Ernste, E. B. H. W., De Reuver, M. J., and Willers, J. M. N., 1988, Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharideconjugate vaccines, Infect. Immun. 56:1391–1393.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vaxcel, Inc., Norcross, Georgia, 30071, USA

    Robert N. Brey

Authors
  1. Robert N. Brey
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Genentech, Inc., South San Francisco, California, USA

    Michael F. Powell

  2. Vaxcel, Inc., Norcross, Georgia, USA

    Mark J. Newman

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Brey, R.N. (1995). Development of Vaccines Based on Formulations Containing Nonionic Block Copolymers. In: Powell, M.F., Newman, M.J. (eds) Vaccine Design. Pharmaceutical Biotechnology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1823-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1823-5_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5737-7

  • Online ISBN: 978-1-4615-1823-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation